Institutional Ownership Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT). We have compiled data on the 244 institutions that hold shares in the stock, with a total of 108 Million shares, which have been reported (via 13F filing form) to have a value of $1.18 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Massmutual Trust CO Fsb
|
Jan 16, 2025 Q4 2024 |
34
shares
|
$355
0.0% of portfolio
|
Q4 2024
New holding
|
|
Lazard Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
30
shares
|
$314
0.0% of portfolio
|
Q3 2024
Reduced 61.54%
|
|
First Horizon Advisors, Inc.
|
Feb 03, 2025 Q4 2024 |
24
shares
|
$251
0.0% of portfolio
|
Q3 2023
Reduced 53.85%
|
|
Allworth Financial LP
|
Jan 30, 2025 Q4 2024 |
23
shares
|
$240
0.0% of portfolio
|
Q4 2024
Added 109.09%
|
|
Ifp Advisors, Inc
|
Feb 04, 2025 Q4 2024 |
14
shares
|
$146
0.0% of portfolio
|
Q4 2024
New holding
|
|
Wealth Trak Capital Management LLC
Virginia Beach, VA |
Feb 12, 2025 Q4 2024 |
10
shares
|
$104
0.0% of portfolio
|
Q4 2024
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|
|
Nomura Asset Management CO LTD
Tokyo, M0 |
Feb 12, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|